175 related articles for article (PubMed ID: 38322729)
21. Photodynamic diagnosis and therapy and the brain.
Kostron H
Methods Mol Biol; 2010; 635():261-80. PubMed ID: 20552352
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy in the treatment of brain tumours. A feasibility study.
Vanaclocha V; Sureda M; Azinovic I; Rebollo J; Cañón R; Sapena NS; Cases FG; Brugarolas A
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):422-7. PubMed ID: 26073912
[TBL] [Abstract][Full Text] [Related]
23. PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
Ong YH; Kim MM; Finlay JC; Dimofte A; Singhal S; Glatstein E; Cengel KA; Zhu TC
Phys Med Biol; 2017 Dec; 63(1):015031. PubMed ID: 29106380
[TBL] [Abstract][Full Text] [Related]
24. Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells.
Miki Y; Akimoto J; Hiranuma M; Fujiwara Y
J Toxicol Sci; 2014; 39(6):821-7. PubMed ID: 25374373
[TBL] [Abstract][Full Text] [Related]
25. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX.
Beck TJ; Kreth FW; Beyer W; Mehrkens JH; Obermeier A; Stepp H; Stummer W; Baumgartner R
Lasers Surg Med; 2007 Jun; 39(5):386-93. PubMed ID: 17565715
[TBL] [Abstract][Full Text] [Related]
26. Red light photodynamic therapy for actinic keratosis using 37 J/cm
Vignion-Dewalle AS; Baert G; Devos L; Thecua E; Vicentini C; Mortier L; Mordon S
Lasers Surg Med; 2017 Sep; 49(7):686-697. PubMed ID: 28370134
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
28. Comparison of actual and simulated tumoricidal effects induced by photodynamic therapy.
Jin W; Shi X; Yin H; Zhang H; Wang Z; Chen Q; Wu H; Han Y; Li Y
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102060. PubMed ID: 33065301
[TBL] [Abstract][Full Text] [Related]
29. 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas.
Mahmoudi K; Garvey KL; Bouras A; Cramer G; Stepp H; Jesu Raj JG; Bozec D; Busch TM; Hadjipanayis CG
J Neurooncol; 2019 Feb; 141(3):595-607. PubMed ID: 30659522
[TBL] [Abstract][Full Text] [Related]
30. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
Albert I; Hefti M; Luginbuehl V
Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
[TBL] [Abstract][Full Text] [Related]
31. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
32. ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia.
Fisher CJ; Niu C; Foltz W; Chen Y; Sidorova-Darmos E; Eubanks JH; Lilge L
PLoS One; 2017; 12(7):e0181654. PubMed ID: 28759636
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Studies with Glioblastoma Brain Organoid Co-Cultures Show Efficient 5-ALA Photodynamic Therapy.
Pedrosa L; Bedia C; Diao D; Mosteiro A; Ferrés A; Stanzani E; Martínez-Soler F; Tortosa A; Pineda E; Aldecoa I; Centellas M; Muñoz-Tudurí M; Sevilla A; Sierra À; González Sánchez JJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190034
[TBL] [Abstract][Full Text] [Related]
34. Hybrid lipid-biopolymer nanocarrier as a strategy for GBM photodynamic therapy (PDT).
Barbosa HFG; Piva HL; Matsuo FS; de Lima SCG; de Souza LEB; Osako MK; Tedesco AC
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124647. PubMed ID: 37146851
[TBL] [Abstract][Full Text] [Related]
35. Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer.
Lilge L; Wu J; Xu Y; Manalac A; Molenhuis D; Schwiegelshohn F; Vesselov L; Embree W; Nesbit M; Betz V; Mandel A; Jewett MAS; Kulkarni GS
J Biomed Opt; 2020 Jun; 25(6):1-13. PubMed ID: 32529817
[TBL] [Abstract][Full Text] [Related]
36. Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro.
Fanuel-Barret D; Patrice T; Foultier MT; Vonarx-Coinsmann V; Robillard N; Lajat Y
Res Exp Med (Berl); 1997; 197(4):219-33. PubMed ID: 9440140
[TBL] [Abstract][Full Text] [Related]
37. Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.
Sun H; Ong Y; Yang W; Sourvanos D; Dimofte A; Busch TM; Singhal S; Cengel KA; Zhu TC
J Biomed Opt; 2024 Jan; 29(1):018001. PubMed ID: 38223299
[TBL] [Abstract][Full Text] [Related]
38. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
39. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.
Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W
J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
